טוען...

Does the addition of ketotifen to non-steroidal anti-inflammatory drugs confer any additional benefit in rheumatoid arthritis?

Ketotifen (benzocycloheptathiophene) was evaluated in a double-blind study of patients with active rheumatoid arthritis. Sixty patients were randomly allocated to receive active or matching placebo drug and reviewed 6 weekly for 24 weeks. Conventional NSAIDs were continued throughout. Disease activi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Teh, L G, Madhok, R, Capell, H A
פורמט: Artigo
שפה:Inglês
יצא לאור: 1984
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1463324/
https://ncbi.nlm.nih.gov/pubmed/6704285
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!